Maternal respiratory syncytial virus (RSV) vaccination and infant nirsevimab immunization, administered alone or sequentially ...
A large Canadian study suggests that nirsevimab, a long-acting monoclonal antibody used to prevent respiratory syncytial ...
Immunization with the long-acting monoclonal antibody nirsevimab may provide stronger protection against hospitalizations for ...
Maternal respiratory syncytial virus (RSV) vaccination and infant nirsevimab immunization, administered alone or sequentially ...
The PAS Meeting connects thousands of leading pediatric researchers, clinicians, and educators worldwide, united by a shared mission: connecting the global academic pediatric community to advance ...
When Parliament moved to amend the National Health Act and broaden the legal definition of ‘vaccine’, only five senators ...
Surveillance captured 16,775 RSV-associated hospitalizations/ED visits; median age was 10 months, with 41% of hospitalizations in infants ≤7 months and most encounters managed in the ED.
Pediatricians are calling on the Alberta government to provide a preventative RSV shot for free to all newborns this fall, saying the move could spare many babies from getting very sick and reduce ...
A mother’s story underscores the stakes as Ireland weighs the cost and benefits of wider RSV immunisation rollout ...
An FDA official told a room of Make America Healthy Again supporters Monday that the agency needs data to make any changes to ...
We all know the risks of influenza and COVID for older people. But a third virus, RSV, can also land you in hospital. A free vaccination aims to reduce this risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results